- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01936272
Essai contrôlé randomisé de Shunt vs ETV/CPC pour PIH chez les nourrissons ougandais
Résultats neurocognitifs et modifications du volume du cerveau et du liquide céphalo-rachidien (LCR) après le traitement de l'hydrocéphalie post-infectieuse (PIH) chez les nourrissons ougandais par shunt versus ETV/CPC
Two treatment options exist for infant patients with hydrocephalus. Most patients are treated with a surgical procedure in which a shunt is inserted into the brain and abdomen. In recent years, however, another treatment has developed called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC).This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This study will evaluate patients in more detail to measure brain growth and development.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
World over, infants with hydrocephalus are mainly treated using a shunt, which is a device made of soft plastic tubing that moves extra fluid from the brain to the abdomen. Surgery is required to insert a shunt into the brain and the abdomen. In recent years, we have developed another treatment called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC). This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This is the most common cause of hydrocephalus in Ugandan babies. This study will evaluate patients in more detail to measure brain growth and development. Children in the study will have special testing to measure developmental progress as well as special imaging to evaluate the progress of their brain growth.
Type d'étude
Inscription (Réel)
Phase
- Phase 3
Contacts et emplacements
Lieux d'étude
-
-
-
Mbale, Ouganda
- CURE Children's Hospital Uganda
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Infants less than 180 days (six months) old
- Symptomatic hydrocephalus
- Post-infectious Hydrocephalus based on clinical and CT parameters2
- Must be from the following Ugandan districts: Bugiri, Busia, Iganga, Jinja, Kampala, Kamuli, Kapchorwa, Katakwi, Kumi, Mayuge, Mbale, Mukono, Pallisa, Sironko, Soroti, and Tororo
Exclusion Criteria:
- Any patient with a scalp erosion or infection that would exclude the patient from shunt implantation
- Any patient with ventricular loculations that would normally indicate the use of ventriculoscopy as an adjunct to shunt placement
- Any patient with absence of any visible cortical mantle on the CT
- Patients must be appropriate candidates for either surgical procedure - shunt placement alone or ETV/CPC
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Chhabra Shunt Placement
The shunting arm will comprise a standard frontal approach ventriculoperitoneal shunt using a silastic Chhabra system. |
|
|
Comparateur actif: ETV/CPC
The Endoscopic Third Ventriculostomy/Choroid Plexus Cauterization (ETV/CPC) arm will comprise a standard frontal approach with flexible endoscopy. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change of Age-normed Bayley Scales of Infant Development (BSID)-III scores
Délai: 12 months and 24 months post treatment
|
Neurocognition will be measured using the BSID-III Cognitive Scale. Change will be assessed at 24 months post treatment from baseline score (12 months post treatment). |
12 months and 24 months post treatment
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Brain Volume
Délai: 12 months, 24 months, 5 years, and 7-10 years post treatment
|
Volume unit of measure is cubic millimeters. Volume is measured using CT scans. |
12 months, 24 months, 5 years, and 7-10 years post treatment
|
|
CSF Volume
Délai: 12 months, 24 months, 5 years, and 7-10 years post treatment
|
Volume unit of measure is cubic millimeters. Volume is measured using CT scans. |
12 months, 24 months, 5 years, and 7-10 years post treatment
|
|
Vineland Adaptive Behavior Scales
Délai: 5 years and 7-10 years post treatment
|
The primary purpose of the VABS is to assess the social abilities of school age children. |
5 years and 7-10 years post treatment
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Benjamin C Warf, MD, Boston Children's Hospital
Publications et liens utiles
Publications générales
- Harper JR, Cherukuri V, O'Reilly T, Yu M, Mbabazi-Kabachelor E, Mulando R, Sheth KN, Webb AG, Warf BC, Kulkarni AV, Monga V, Schiff SJ. Assessing the utility of low resolution brain imaging: treatment of infant hydrocephalus. Neuroimage Clin. 2021;32:102896. doi: 10.1016/j.nicl.2021.102896. Epub 2021 Nov 23.
- Punchak M, Mbabazi Kabachelor E, Ogwal M, Nalule E, Nalwoga J, Ssenyonga P, Mugamba J, Rattani A, Dewan MC, Kulkarni AV, Schiff SJ, Warf B. The Incidence of Postoperative Seizures Following Treatment of Postinfectious Hydrocephalus in Ugandan Infants: A Post Hoc Comparison of Endoscopic Treatment vs Shunt Placement in a Randomized Controlled Trial. Neurosurgery. 2019 Oct 1;85(4):E714-E721. doi: 10.1093/neuros/nyz122.
- Kulkarni AV, Schiff SJ, Mbabazi-Kabachelor E, Mugamba J, Ssenyonga P, Donnelly R, Levenbach J, Monga V, Peterson M, MacDonald M, Cherukuri V, Warf BC. Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda. N Engl J Med. 2017 Dec 21;377(25):2456-2464. doi: 10.1056/NEJMoa1707568.
- Rattani A, Spencer JC, Agwu CK, Dewan MC, Kabachelor EM, Ssenyonga P, Mugamba J, Schiff SJ, Kulkarni AV, Warf BC. Five-Year Cost-Effectiveness Analysis of Endoscopic Third Ventriculostomy With Choroid Plexus Cauterization Versus Ventriculoperitoneal Shunting in Postinfectious Hydrocephalus in a Low-Income Setting. Neurosurgery. 2026 Sep 18. doi: 10.1227/neu.0000000000004218. Online ahead of print.
- Mukherjee S, Templeton K, Tindimwebwa S, Lin PY, Sutin J, Yu M, Peterson M, Truwit C, Schiff SJ, Monga V. GLAPAL-H: Global, Local, and Parts Aware Learner for Hydrocephalus Infection Diagnosis in Low-Field MRI. IEEE Trans Biomed Eng. 2026 Jan;73(1):139-152. doi: 10.1109/TBME.2025.3578541.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimé)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- P00002785
- R01HD085853 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
IPD will not be shared with researchers outside of the study team.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .